Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones

References

• Bekhit AA, Fahmy HTY, Rostom SAF, Baraka AM. Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial agents. Eur J Med Chem 2003;38:27–36
   PubMed Web of Science ®Google Scholar
• Khanna IK, Yu Y, Huff RM, et al. Selective Cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents. J Med Chem 2000;43:3168–85
   PubMed Web of Science ®Google Scholar
• Frank MM, Fries LF. The role of complement in inflammation and phagocytosis. Immunol Today 1991;12:322–6
   PubMedGoogle Scholar
• Collier HOJ. Prostaglandins and aspirin. Nature 1971;232:17–19
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage. Arch Intern Med 1992;152:1145–55
   PubMed Web of Science ®Google Scholar
• Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Eng J Med 1984;310:563–72
   PubMed Web of Science ®Google Scholar
• Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Eng J Med 1992;327:749–54
   PubMed Web of Science ®Google Scholar
• Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996;16:181–206
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato M, Kakinuma H, et al. Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors. J Med Chem 2003;46:5416–27
   PubMed Web of Science ®Google Scholar
• Cheng H, DeMello KML, Li J, et al. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Bioorg Med Chem Lett 2006;16:2076–80
   PubMed Web of Science ®Google Scholar
• Bekhit AA, Ashour HMA, Ghany YSA, et al. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents. Eur J Med Chem 2008;43:456–63
   PubMed Web of Science ®Google Scholar
• El-Sayed MA-A, Abdel-Aziz NI, Abdel-Aziz AA-M, et al. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: molecular docking study. Bioorg Med Chem 2011;19:3416–24
   PubMed Web of Science ®Google Scholar
• Nagarapu L, Materi J, Gaikwad HK, et al. Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives. Bioorg Med Chem Lett 2011;21:4138–40
   PubMed Web of Science ®Google Scholar
• Ahlstrom MM, Ridderstrom M, Zamora I, Luthman K. CYP2C9 Structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors. J Med Chem 2007;50:4444–52
   PubMed Web of Science ®Google Scholar
• Prakash O, Kumar R, Parkash V. Synthesis and antifungal activity of some new 3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromones. Eur J Med Chem 2008;43:435–40
   PubMed Web of Science ®Google Scholar
• Brough PA, Aherne W, Barril X, et al. 4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem 2008;51:196–218
   PubMed Web of Science ®Google Scholar
• Vera-DiVaio MAF, Freitas ACC, Castro HCA, et al. Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series. Bioorg Med Chem 2009;17:295–302
   PubMed Web of Science ®Google Scholar
• Singh P, Paul K, Holzer W. Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators. Bioorg Med Chem 2006;14:5061–71
   PubMed Web of Science ®Google Scholar
• Hsu TC, Robins RK, Cheng CC. Studies on 4APP: antineoplastic action in vitro. Science 1956;13:848–68
   Web of Science ®Google Scholar
• Storer R, Ashton CJ, Baxter AD, et al. The synthesis and antiviral activity of 4-fluoro-1-β-d-ribofuranosyl-1h-pyrazole-3-carboxamide. Nucleosides Nucleotides Nucleic Acids 1999;18:203–16
   Web of Science ®Google Scholar
• Genin MJ, Biles C, Keiser BJ, et al. Novel 1,5-diphenylpyrazole nonnucleoside hiv-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. J Med Chem 2000;43:1034–40
   PubMed Web of Science ®Google Scholar
• Qiao JX, Pinto DJ, Orwat MJ, et al. Preparation of 1,1-disubstituted cycloalkyl derivatives as factor Xa inhibitors for treating a thromboembolic disorder. PCT Int Appl WO 03 99, 276 (Chem Abstr 2004;140:16722g)
   Google Scholar
• Baraldi PG, Bovero A, Fruttarolo F, et al. New strategies for the synthesis of A3 adenosine receptor antagonists. Bioorg Med Chem 2003;11:4161–9
   PubMed Web of Science ®Google Scholar
• Stamford AW, Wu Y. Preparation of N-(phenyl)pyrazolyl-N′-piperidinylureas as neuropeptide Y Y5 receptor antagonists. PCT Int Appl WO 2004, 5262 (Chem. Abstr. 2004;140:11141p)
   Google Scholar
• Brown ML, Cheung M, Dickerson SH, et al. Preparation of pyrazolopyrimidines as kinase inhibitors for the treatment of type 2 diabetes. PCT Int Appl WO 2004, 9596 (Chem. Abstr. 2004;140:128436y)
   Google Scholar
• Heerding DA. Preparation of arylazopyrazoles as thrombopoietin mimetics. PCT Int Appl WO 03 103686 (Chem. Abstr. 2004;140: 42170v)
   Google Scholar
• Duma J, Hatoum-Mokdad H, Sibley R, et al. 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett 2000;10:2051–4
   PubMed Web of Science ®Google Scholar
• Reynold JEF, ed. The extra pharmacopia, 30th ed. Martindale, London: Pharmaceutical Press; 1993. 1 p
   Google Scholar
• Amir M, Kumar S. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines. Indian J Chem Sec B 2005;44B:2532–7
   Google Scholar
• Gursoy A, Demirayak S, Capan G, et al. Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents. Eur J Med Chem 2000;35:359–64
   PubMed Web of Science ®Google Scholar
• Kumar A, Sharma S, Bajaj K, et al. Synthesis and anti-inflammatory, analgesic, ulcerogenic and cyclooxegenase activity of novel quinazolinyl-Δ2-pyrazolines. Indian J Chem Sec B 2003;42B:1979–84
   Google Scholar
• Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999;6:1125–49
   PubMed Web of Science ®Google Scholar
• Go ML, Wu X, Liu XL. Chalcones: an update on cytotoxic and chemoprotective properties. Curr Med Chem 2005;12:483–99
   Web of Science ®Google Scholar
• Kontogiorgis C, Mantzanidou M, Hadjipavlou-Litina D. Chalcones and their potential role in inflammation. Mini Rev Med Chem 2008;8:1224–42
   PubMed Web of Science ®Google Scholar
• Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125–37
   PubMed Web of Science ®Google Scholar
• Bandgar BP, Gawande SS, Bodade RG, et al. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg Med Chem 2009;17:8168–73
   PubMed Web of Science ®Google Scholar
• Bandgar BP, Gawande SS, Bodade RG, et al. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg Med Chem 2010;18:1364–70
   PubMed Web of Science ®Google Scholar
• Chavan HV, Bandgar BP, Adsul LK, et al. Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones. Bioorg Med Chem Lett 2013;23:1315–21
   PubMed Web of Science ®Google Scholar
• Bandgar BP, Chavan HV, Adsul LK, et al. Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones. Bioorg Med Chem Lett 2013;23:912–16
   PubMed Web of Science ®Google Scholar
• Bandgar BP, Adsul LK, Chavan HV, et al. Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors. Bioorg Med Chem 2012;20:5649–57
   PubMed Web of Science ®Google Scholar
• Bandgar BP, Patil SA, Totre JV, et al. Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-α and IL-6 inhibitors with antioxidant activity. Bioorg Med Chem Lett 2010;20:2292–6
   PubMed Web of Science ®Google Scholar
• Maurias M, Handler N, Erker T, et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship. Bioorg Med Chem 2004;12:5571–8
   PubMed Web of Science ®Google Scholar
• Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med 1962;111:544--74
   PubMed Web of Science ®Google Scholar
• Winter CA, Portar CC. Effect of alterations in the side chain upon anti-inflammatory and liver glycogen activities of hydrocortisone esters. J Am Pharm Assoc Sci Educ 1957;46:515–19
   Web of Science ®Google Scholar
• Ahluwalia VK. Intermediates for organic synthesis. New Delhi, India: I. K. International Publisher; 2005. 140 p
   Google Scholar